UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
| (Mark One) | ||
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended April 2, 2005
OR
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 000-17157
NOVELLUS SYSTEMS, INC.
| California | 77-0024666 | |
| (State or other jurisdiction of | (I.R.S. Employer Identification | |
| incorporation of organization) | Number) |
4000 North First Street, San Jose, California 95134
(Address of principal executive offices including zip code)
(408) 943-9700
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES þ NO o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
YES þ NO o
As of April 29, 2005, 138,109,942 shares of the Registrants common stock, no par value, were issued and outstanding.
NOVELLUS SYSTEMS, INC.
FORM 10-Q
QUARTER ENDED APRIL 2, 2005
TABLE OF CONTENTS
| Page | ||||||||
| 3 | ||||||||
| 3 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 13 | ||||||||
| 26 | ||||||||
| 26 | ||||||||
| 27 | ||||||||
| 27 | ||||||||
| 28 | ||||||||
| 28 | ||||||||
| 29 | ||||||||
| EXHIBIT 10.31 | ||||||||
| EXHIBIT 10.32 | ||||||||
| EXHIBIT 31.1 | ||||||||
| EXHIBIT 31.2 | ||||||||
| EXHIBIT 32.1 | ||||||||
| EXHIBIT 32.2 | ||||||||
2
PART I: FINANCIAL INFORMATION
ITEM 1: CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
| Quarters Ended | ||||||||
| April 2, 2005 | March 27, 2004 | |||||||
Net sales |
$ | 339,740 | $ | 262,862 | ||||
Cost of sales |
185,871 | 138,257 | ||||||
Gross profit |
153,869 | 124,605 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
51,760 | 42,403 | ||||||
Research and development |
62,048 | 58,957 | ||||||
Legal settlement |
| 2,500 | ||||||
Total operating expenses |
113,808 | 103,860 | ||||||
Operating income |
40,061 | 20,745 | ||||||
Interest income, net |
3,060 | 2,455 | ||||||
Other income, net |
409 | 294 | ||||||
Interest and other, net |
3,469 | 2,749 | ||||||
Income before income taxes |
43,530 | 23,494 | ||||||
Provision for income taxes |
13,059 | 6,813 | ||||||
Net income |
$ | 30,471 | $ | 16,681 | ||||
Net income per share: |
||||||||
Basic net income per share |
$ | 0.22 | $ | 0.11 | ||||
Diluted net income per share |
$ | 0.22 | $ | 0.11 | ||||
Shares used in basic per share calculation |
139,890 | 152,911 | ||||||
Shares used in diluted per share calculation |
141,099 | 156,100 | ||||||
See accompanying notes to condensed consolidated financial statements.
3
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
| April 2, | December 31, | |||||||
| 2005 | 2004 * | |||||||
| (unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 124,363 | $ | 106,117 | ||||
Short-term investments |
548,150 | 481,645 | ||||||
Accounts receivable, net |
347,295 | 395,522 | ||||||
Inventories |
246,856 | 261,046 | ||||||
Deferred tax assets, net |
113,422 | 110,644 | ||||||
Prepaid and other current assets |
21,132 | 14,350 | ||||||
Total current assets |
1,401,218 | 1,369,324 | ||||||
Property and equipment, net |
467,391 | 476,492 | ||||||
Restricted cash and cash equivalents |
171,406 | 176,708 | ||||||
Goodwill |
273,709 | 278,972 | ||||||
Intangible and other assets |
98,548 | 100,336 | ||||||
Total assets |
$ | 2,412,272 | $ | 2,401,832 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 66,709 | $ | 70,446 | ||||
Accrued payroll and related expenses |
42,421 | 64,531 | ||||||
Accrued warranty |
47,979 | 45,526 | ||||||
Other accrued liabilities |
55,595 | 54,517 | ||||||
Income taxes payable |
25,646 | 14,691 | ||||||
Deferred profit |
72,148 | 71,216 | ||||||
Current obligations under lines of credit |
1,574 | 3,103 | ||||||
Total current liabilities |
312,072 | 324,030 | ||||||
Long term debt |
150,280 | 161,103 | ||||||
Other liabilities |
52,124 | 54,865 | ||||||
Total liabilities |
514,476 | 539,998 | ||||||
Shareholders equity: |
||||||||
Common stock |
1,481,951 | 1,473,829 | ||||||
Deferred stock compensation |
(15,591 | ) | (17,159 | ) | ||||
Retained earnings |
430,223 | 399,919 | ||||||
Accumulated other comprehensive income |
1,213 | 5,245 | ||||||
Total shareholders equity |
1,897,796 | 1,861,834 | ||||||
Total liabilities and shareholders equity |
$ | 2,412,272 | $ | 2,401,832 | ||||
| * | Amounts as of December 31, 2004 are derived from the December 31, 2004 audited financial statements. |
See accompanying notes to condensed consolidated financial statements.
4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
| Quarters Ended | ||||||||
| April 2, | March 27, | |||||||
| 2005 | 2004 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 30,471 | $ | 16,681 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Gain on sale of an investment |
| (348 | ) | |||||
Loss on sale of fixed assets |
287 | | ||||||
Depreciation and amortization |
21,275 | 20,547 | ||||||
Deferred income taxes |
(1,158 | ) | (10,081 | ) | ||||
Stock-based compensation |
1,213 | 979 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
43,526 | (53,338 | ) | |||||
Inventories |
9,300 | (18,909 | ) | |||||
Prepaid and other current assets |
(5,618 | ) | 168 | |||||
Accounts payable |
(3,193 | ) | 32,098 | |||||
Accrued payroll and related expenses |
(21,889 | ) | 12,253 | |||||
Accrued warranty |
2,554 | 5,245 | ||||||
Other accrued liabilities |
(825 | ) | (1,954 | ) | ||||
Income taxes payable |
12,412 | 9,630 | ||||||
Deferred profit |
1,095 | 17,153 | ||||||
Net cash provided by operating activities |
89,450 | 30,124 | ||||||
Cash flows from investing activities: |
||||||||
Proceeds from sales of short-term investments |
43,750 | 74,721 | ||||||
Proceeds from maturities of short-term investments |
49,813 | 132,799 | ||||||
Purchases of short-term investments |
(161,356 | ) | (241,256 | ) | ||||
Capital expenditures |
(15,396 | ) | (5,306 | ) | ||||
Proceeds from sale of fixed assets |
2,591 | | ||||||
Decrease in other assets |
1,600 | 2,261 | ||||||
Decrease (increase) in restricted cash and cash equivalents |
5,302 | (204 | ) | |||||
Net cash used in investing activities |
(73,696 | ) | (36,985 | ) | ||||
Cash flows from financing activities: |
||||||||
Proceeds from employee stock compensation plans |
8,310 | 10,137 | ||||||
(Payments on) proceeds from lines of credit, net |
(1,494 | ) | 8,646 | |||||
Payments on long-term debt |
(5,288 | ) | | |||||
Repurchase of common stock |
| (15,265 | ) | |||||
Net cash provided by financing activities |
1,528 | 3,518 | ||||||
Effects of exchange rate changes on cash and cash equivalents |
964 | 171 | ||||||
Net increase (decrease) in cash and cash equivalents |
18,246 | (3,172 | ) | |||||
Cash and cash equivalents at the beginning of the period |
106,117 | 497,178 | ||||||
Cash and cash equivalents at the end of the period |
$ | 124,363 | $ | 494,006 | ||||
See accompanying notes to condensed consolidated financial statements.
5
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION AND STOCK-BASED COMPENSATION
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. The interim financial information is unaudited and does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the quarter ended April 2, 2005 are not necessarily indicative of the results that may be expected for the year ending December 31, 2005. For further information, please refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2004.
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to revenue recognition, allowance for doubtful accounts, inventory valuation, deferred tax assets, property and equipment, goodwill and other intangible assets, warranty obligations, restructuring and impairment charges, contingencies and litigation, and stock-based compensation. We base our estimates on historical experience and on other assumptions that are believed to be reasonable under the current circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our intent is to accurately state our assets given facts known at the time of valuation. Our assumptions may prove incorrect as facts change in the future. Actual results may differ from these estimates under different assumptions or conditions.
The accompanying condensed consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries after the elimination of all significant intercompany account balances and transactions. Certain prior period balances have been reclassified to conform to the current period presentation.
On June 28, 2004, we acquired Peter Wolters AG, a manufacturer of high-precision machine manufacturing tools. The acquisition was accounted for as a purchase business combination in accordance with SFAS No. 141. Our consolidated financial statements for the period ended April 2, 2005 include the financial position, results of operations and cash flows of Peter Wolters. Due to the divergence of Peter Wolters existing product lines and customer base from the operating segment in which we primarily operate, we have included a new segment in our disclosures. We refer to this segment as our Industrial Applications Group.
Stock-Based Compensation
We account for stock-based employee compensation using the intrinsic value method under Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, or APB No. 25, and have adopted the disclosure-only provisions of Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation, or SFAS No. 123, as amended by SFAS No. 148, Accounting for Stock-Based Compensation Transition and Disclosures. Accordingly, no expense has been recognized for options granted to employees at fair value.
In our consolidated statements of operations we recognize stock-based compensation, measured at the intrinsic value, on the graded vesting method over the vesting periods for restricted stock awards and stock options, which is generally four years. The graded vesting method provides for vesting of portions of the overall awards at interim dates and results in greater expense recorded in earlier years than the straight-line method.
In the disclosure presented below we recognize stock-based compensation, measured at the fair value, on the graded vesting method over the vesting periods for restricted stock awards and stock options, which is generally four years, and for employee purchases of common stock under our employee stock purchase plan, which is generally six months. The graded vesting method provides for vesting of portions of the overall awards at interim dates and results in greater expense recorded in earlier years than the straight-line method.
6
SFAS No. 123 requires the use of option pricing models, most of which were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange-traded options that have no vesting restrictions and are freely transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the options expected life and the price volatility of the underlying stock. Since our employee stock options have characteristics significantly different from those of traded options and since changes in the subjective input assumptions can materially affect the fair value estimate, in our opinion, the existing models may not necessarily provide a reliable single measure of the fair value of employee stock options.
Had compensation expense been determined based on the fair value as determined by the Black-Scholes model at the grant date for awards, consistent with the provisions of SFAS No. 123, we would have reported pro forma net income and net income per share as follows (in thousands, except per share data):
| Quarters Ended | ||||||||
| April 2, | March 27, | |||||||
| 2005 | 2004 | |||||||
Net income as reported |
$ | 30,471 | $ | 16,681 | ||||
Add: |
||||||||
Intrinsic value method expense
included in reported net
income, net of related tax effects |
849 | 978 | ||||||
Less: |
||||||||
Fair value method expense, net of
related tax effects |
(10,573 | ) | (13,803 | ) | ||||
Pro-forma net income |
$ | 20,747 | $ | 3,856 | ||||
Pro-forma basic and diluted net income
per share |
$ | 0.15 | $ | 0.03 | ||||
Basic net income per share
as reported |
$ | 0.22 | $ | 0.11 | ||||
Diluted net income per share
as reported |
$ | 0.22 | $ | 0.11 | ||||
The fair value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model, with the following weighted-average assumptions for grants made in the quarters ended April 2, 2005 and March 27, 2004, respectively:
| Quarters Ended | |||||
| April 2, | March 27, | ||||
| 2005 | 2004 | ||||
Dividend yield |
None | None | |||
Expected volatility |
70% | 77% | |||
Risk free interest rate |
3.3% | 2.3% | |||
Expected lives |
3.7 years | 3.7 years | |||
The weighted-average fair value of stock options granted during the period was $14.46 and $17.89 for the quarters ended April 2, 2005 and March 27, 2004, respectively.
The pro forma net income and net income per share data listed above include expense related to the Employee Stock Purchase Plan, referred to herein as the Purchase Plan. The fair value of issuances under the Purchase Plan is estimated using the Black-Scholes option-pricing model, with the following weighted-average assumptions:
| Quarters Ended | |||||
| April 2, | March 27, | ||||
| 2005 | 2004 | ||||
Dividend yield |
None | None | |||
Expected volatility |
40% | 45% | |||
Risk free interest rate |
2.1% | 1.3% | |||
Expected lives |
0.5 year | 0.5 year | |||
The weighted-average fair value of purchase rights was $6.96 and $10.59 for the quarters ended April 2, 2005 and March 27, 2004, respectively.
7
Recent Accounting Pronouncements
On December 16, 2004, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 123 (revised 2004), Share-Based Payment, or Statement 123(R), which is a revision of FASB Statement No. 123, Accounting for Stock-Based Compensation. Statement 123(R) supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees, or Opinion 25, and amends FASB Statement No. 95, Statement of Cash Flows. Generally, the approach in Statement 123(R) is similar to the approach described in the unrevised Statement 123. However, Statement 123(R) requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative. In April 2005, the Securities and Exchange Commission (SEC) deferred the effective date of Statement 123(R) until the first fiscal year beginning after June 15, 2005, with early adoption permitted. We expect to adopt Statement 123(R) on January 1, 2006.
As permitted by the unrevised Statement 123, we currently account for share-based payments to employees using Opinion 25s intrinsic value method, under which we generally do not record compensation cost for employee stock options. Accordingly, the adoption of Statement 123(R)s fair value method will have a significant impact on our results of operations, although it will have no impact on our overall financial position. The precise impact of adoption of Statement 123(R) cannot be predicted at this time because it will depend, in part, on levels of share-based payments granted in the future. However, had we adopted Statement 123(R) in prior periods, the impact of that standard would have approximated the impact of Statement 123 as described in the disclosure of pro forma net income and earnings per share in Note 1 to our Condensed Consolidated Financial Statements. Statement 123(R) also requires the benefits of tax deductions in excess of recognized compensation cost to be reported as a financing cash flow, rather than as an operating cash flow as required under current literature. This requirement will reduce net operating cash flows and increase net financing cash flows in periods after adoption. While we cannot estimate what those amounts will be in the future (because they depend on, among other things, when employees exercise stock options), the amount of operating cash flows recognized in prior years for such excess tax deductions were zero in 2004 and 2003, and $19.4 million in 2002.
In March 2005, the SEC issued Staff Accounting Bulletin (SAB) No. 107. SAB 107 provides guidance related to share-based payment transactions with non-employees, the transition from nonpublic to public entity status, valuation methods (including assumptions such as expected volatility and expected term), the accounting for certain redeemable financial instruments issued under share-based payment arrangements, the classification of compensation expense, non-GAAP financial measures, first-time adoption of Statement 123R in an interim period, capitalization of compensation cost related to share-based payment arrangements, the accounting for income tax effects of share-based payment arrangements upon adoption of Statement 123R, the modification of employee share options prior to adoption of Statement 123R and disclosures in Managements Discussion and Analysis (MD&A) subsequent to adoption of Statement 123R. We are currently in the process of assessing the impact of this guidance.
2. NET INCOME PER SHARE
Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. For purposes of computing basic net income per share, the weighted-average number of outstanding shares of common stock excludes shares of restricted stock subject to repurchase.
Diluted net income per share is computed using the weighted-average number of shares of common stock outstanding, including shares of restricted common stock subject to repurchase and, when dilutive, potential shares from stock options to purchase common stock using the treasury stock method.
The following table provides a reconciliation of the numerators and denominators of the basic and diluted per share computations (in thousands, except for per share amounts):
| Quarters Ended | ||||||||
| April 2, | March 27, | |||||||
| 2005 | 2004 | |||||||
Numerator: |
||||||||
Net income |
$ | 30,471 | $ | 16,681 | ||||
Denominator: |
||||||||
Basic weighted-average shares outstanding |
139,890 | 152,911 | ||||||
Employee stock options and restricted stock |
1,209 | 3,189 | ||||||
Diluted weighted-average shares outstanding |
141,099 | 156,100 | ||||||
Basic net income per share |
$ | 0.22 | $ | 0.11 | ||||
Diluted net income per share |
$ | 0.22 | $ | 0.11 | ||||
8
Options to purchase approximately 21.0 million and 11.3 million shares of common stock at a weighted average exercise price of $35.31 and $42.09 per share were outstanding for the quarters ended April 2, 2005 and March 27, 2004, respectively, but were not included in the computation of diluted net income per common share because the respective exercise prices of these options were greater than the average respective market prices of the common shares and, therefore, the effect would be anti-dilutive.
3. OTHER INCOME, NET
The components of other income, net within the consolidated statements of operations are as follows (in thousands):
| Quarters Ended | ||||||||
| April 2, | March 27, | |||||||
| 2005 | 2004 | |||||||
Other income |
$ | 118 | $ | 843 | ||||
Other expense |
(125 | ) | (233 | ) | ||||
Foreign currency gain (loss), net |
416 | (316 | ) | |||||
Total other income, net |
$ | 409 | $ | 294 | ||||
4. INVENTORIES
Inventories are stated at the lower of cost (first-in, first-out) or market. As of the balance sheet date, inventories consisted of the following (in thousands):
| April 2, | December 31, | |||||||
| 2005 | 2004 | |||||||
Purchased and spare parts |
$ | 187,141 | $ | 192,935 | ||||
Work-in-process |
46,890 | 54,586 | ||||||
Finished goods |
12,825 | 13,525 | ||||||
Total inventories |
$ | 246,856 | $ | 261,046 | ||||
5. GOODWILL AND INTANGIBLE ASSETS
Goodwill
A summary of changes in goodwill during the quarters ended April 2, 2005 and March 27, 2004 is as follows (in thousands):
| Quarters Ended | ||||||||||||||||||||||||
| April 2, 2005 | March 27, 2004 | |||||||||||||||||||||||
| Industrial | Industrial | |||||||||||||||||||||||
| Semiconductor | Applications | Semiconductor | Applications | |||||||||||||||||||||
| Group | Group | Total | Group | Group | Total | |||||||||||||||||||
Balance, beginning of period |
$ | 162,230 | $ | 116,742 | $ | 278,972 | $ | 173,267 | $ | | $ | 173,267 | ||||||||||||
SpeedFam-IPEC adjustment |
(1,170 | ) | | (1,170 | ) | | | | ||||||||||||||||
Foreign currency translation |
| (4,093 | ) | (4,093 | ) | | | | ||||||||||||||||
Balance, end of period |
$ | 161,060 | $ | 112,649 | $ | 273,709 | $ | 173,267 | $ | | $ | 173,267 | ||||||||||||
During the quarter ended April 2, 2005, we reduced valuation allowances against certain net operating loss carryforwards recorded during the acquisition of SpeedFam-IPEC in 2002. We accordingly reversed $1.2 million against goodwill. The foreign currency translation effects for the quarter ended April 2, 2005 resulted in a decrease to goodwill of $4.1 million.
In connection to our purchase of Peter Wolters in June 2004, we deposited ten percent of the purchase price into escrow. The escrow amount will be released to the former shareholders of Peter Wolters on June 25, 2005, to the extent we have not made claims against the escrow for pre-acquisition contingencies. Any escrow claims would impact the recorded goodwill amount. No claims were made during the quarter ended April 2, 2005.
We completed the annual goodwill impairment test in the fourth quarter of 2004 in accordance with our policy. The first step of the test identifies when impairment may have occurred, while the second step of the test measures the amount of the impairment, if any.
9
The results of our impairment tests did not indicate impairment. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to our impairment test performed in the fourth quarter of 2004.
Intangible Assets
The following tables provide details of our acquired intangible assets (in thousands):
| Accumulated | ||||||||||||
| April 2, 2005 | Gross | Amortization | Net | |||||||||
Patents |
$ | 4,197 | $ | (699 | ) | $ | 3,498 | |||||
Developed technology |
27,719 | (8,051 | ) | 19,668 | ||||||||
Trademark |
6,570 | (493 | ) | 6,077 | ||||||||
Other intangible assets |
138 | (83 | ) | 55 | ||||||||
Total |
$ | 38,624 | $ | (9,326 | ) | $ | 29,298 | |||||
| Accumulated | ||||||||||||
| December 31, 2004 | Gross | Amortization | Net | |||||||||
Patents |
$ | 4,197 | $ | (525 | ) | $ | 3,672 | |||||
Developed technology |
28,095 | (6,928 | ) | 21,167 | ||||||||
Trademark |
6,809 | (340 | ) | 6,469 | ||||||||
Other intangible assets |
138 | (81 | ) | 67 | ||||||||
Total |
$ | 39,239 | $ | (7,874 | ) | $ | 31,365 | |||||
Our estimated amortization expense for the identifiable intangible assets for each of the next five fiscal years will be approximately $6.0 million for each of 2006 and 2007, $5.7 million for 2008, $3.1 million for 2009 and $1.7 million for 2010. As of April 2, 2005, we have no identifiable intangible assets with indefinite lives.
6. PRODUCT WARRANTY
We record the estimated cost of warranty as a component of cost of sales upon system shipment. The estimated cost is determined by the warranty term as well as the average historical labor and material costs for a specific product. Should actual product failure rates or material usage differ from our estimate, revisions to the estimated warranty liability may be required. We review the actual product failure rates and material usage on a quarterly basis and adjust our warranty liability as necessary. Changes in our accrued warranty liability were as follows (in thousands):
| Quarters Ended | ||||||||
| April 2, | March 27, | |||||||
| 2005 | 2004 | |||||||
Balance, beginning of period |
$ | 45,526 | $ | 28,805 | ||||
Warranties issued |
21,630 | 16,634 | ||||||
Settlements |
(20,304 | ) | (12,585 | ) | ||||
Changes in liability for
pre-existing warranties,
including expirations |
1,127 | 1,196 | ||||||
Balance, end of period |
$ | 47,979 | $ | 34,050 | ||||
7. RESTRUCTURING AND OTHER CHARGES
As of April 2, 2005, substantially all actions under our 2004, 2003, 2002 and 2001 restructuring plans had been completed, except for payments of future rent obligations of $39.5 million, which are to be paid in cash through 2017. There were no significant changes in estimates on sublease income related to these facilities during the quarter ended April 2, 2005. All restructuring and other charges are related to the semiconductor segment.
In 2004, we incurred a restructuring charge to align our research and development and manufacturing operations with current business conditions. In the third quarter of 2003, we implemented a restructuring plan to align our cost structure with business conditions. Additional restructuring reserves recorded in 2002 were primarily related to exiting business activities of SpeedFam-IPEC that were recognized by us as liabilities assumed in the purchase business combination. In 2001, we implemented a restructuring plan that was
10
driven by the decline in sales orders due to the contraction of the semiconductor capital equipment market.
The following table summarizes restructuring activity for the quarter ended April 2, 2005 (in thousands):